BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 25839338)

  • 1. Effects of Shakuyaku-Kanzo-to on Extrapyramidal Symptoms During Antipsychotic Treatment: A Randomized, Open-Label Study.
    Ota T; Miura I; Kanno-Nozaki K; Hoshino H; Horikoshi S; Fujimori H; Kanno T; Mashiko H; Yabe H
    J Clin Psychopharmacol; 2015 Jun; 35(3):304-7. PubMed ID: 25839338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shakuyaku-kanzo-to (Shao-Yao-Gan-Cao-Tang) as Treatment of Painful Muscle Cramps in Patients with Lumbar Spinal Stenosis and Its Minimum Effective Dose.
    Takao Y; Takaoka Y; Sugano A; Sato H; Motoyama Y; Ohta M; Nishimoto T; Mizobuchi S
    Kobe J Med Sci; 2015 Apr; 61(5):E132-7. PubMed ID: 27363396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of orally administered shao-yao-gan-cao-tang (Shakuyaku-kanzo-to) on muscle cramps in maintenance hemodialysis patients: a preliminary study.
    Hinoshita F; Ogura Y; Suzuki Y; Hara S; Yamada A; Tanaka N; Yamashita A; Marumo F
    Am J Chin Med; 2003; 31(3):445-53. PubMed ID: 12943175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biperiden and haloperidol plasma levels and extrapyramidal side effects in schizophrenic patients.
    Meszaros K; Lenzinger E; Hornik K; Schönbeck G; Hatzinger R; Langer G; Sieghart W; Aschauer HN
    Neuropsychobiology; 1997; 36(2):69-72. PubMed ID: 9267855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Herbal medicine Shakuyaku-kanzo-to reduces paclitaxel-induced painful peripheral neuropathy in mice.
    Hidaka T; Shima T; Nagira K; Ieki M; Nakamura T; Aono Y; Kuraishi Y; Arai T; Saito S
    Eur J Pain; 2009 Jan; 13(1):22-7. PubMed ID: 18472288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of shakuyaku-kanzo-to in neuroleptic-induced hyperprolactinemia: a preliminary report.
    Yamada K; Kanba S; Murata T; Fukuzawa M; Terashi B; Yagi G; Asai M
    Psychiatry Clin Neurosci; 1996 Dec; 50(6):341-2. PubMed ID: 9014235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Herbal medicine (Shakuyaku-kanzo-to) improves olanzapine-associated hyperprolactinemia: a case report.
    Hori H; Yoshimura R; Katsuki A; Nakamura J
    J Clin Psychopharmacol; 2013 Feb; 33(1):122-3. PubMed ID: 23288231
    [No Abstract]   [Full Text] [Related]  

  • 8. Possible evidence that the herbal medicine shakuyaku-kanzo-to decreases prostaglandin levels through suppressing arachidonate turnover in endometrium.
    Imai A; Horibe S; Fuseya S; Iida K; Takagi H; Tamaya T
    J Med; 1995; 26(3-4):163-74. PubMed ID: 8558097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-soluble fraction of Shakuyaku-kanzo-to inhibits myometrial contraction in pregnant women.
    Sumi G; Yasuda K; Tsuji S; Kanamori C; Tsuzuki T; Cho H; Nishigaki A; Okada H; Kanzaki H
    J Obstet Gynaecol Res; 2015 May; 41(5):670-9. PubMed ID: 25421109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Herbal medicine (Shakuyaku-kanzo-to) in the treatment of risperidone-induced amenorrhea.
    Yamada K; Kanba S; Yagi G; Asai M
    J Clin Psychopharmacol; 1999 Aug; 19(4):380-1. PubMed ID: 10440470
    [No Abstract]   [Full Text] [Related]  

  • 11. [The efficacy of Shakuyaku-Kanzo-to for peripheral nerve dysfunction in paclitaxel combination chemotherapy for epithelial ovarian carcinoma].
    Fujii K; Okamoto S; Saitoh K; Sasaki N; Takano M; Tanaka S; Kudoh K; Kita T; Tode T; Kikuchi Y
    Gan To Kagaku Ryoho; 2004 Oct; 31(10):1537-40. PubMed ID: 15508446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risperidone-induced extrapyramidal side effects: is the need for anticholinergics the consequence of high plasma concentrations?
    Schoretsanitis G; Haen E; Hiemke C; Gründer G; Stegmann B; Schruers KR; Veselinovic T; Lammertz SE; Paulzen M
    Int Clin Psychopharmacol; 2016 Sep; 31(5):259-64. PubMed ID: 27167902
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of antiparkinson agents in preventing antipsychotic-induced extrapyramidal symptoms.
    Murphy JE; Stewart RB
    Am J Hosp Pharm; 1979 May; 36(5):641-4. PubMed ID: 36755
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Placebo-level incidence of extrapyramidal symptoms (EPS) with quetiapine in controlled studies of patients with bipolar mania.
    Nasrallah HA; Brecher M; Paulsson B
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):467-74. PubMed ID: 17042884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of herbal medicine (shakuyaku-kanzo-to) for neuroleptic-induced hyperprolactinemia.
    Yamada K; Kanba S; Yagi G; Asai M
    J Clin Psychopharmacol; 1997 Jun; 17(3):234-5. PubMed ID: 9169978
    [No Abstract]   [Full Text] [Related]  

  • 16. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
    Silver H; Geraisy N; Schwartz M
    J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Recent research trends in diagnosis, treatment, and prevention of drug-induced extrapyramidal symptoms seen in psychiatric patients].
    Inada T
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1996 Oct; 16(5):181-5. PubMed ID: 8962437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Two-step inhibitory effect of kanzo on oxytocin-induced and prostaglandin F2α-induced uterine myometrial contractions.
    Sumi G; Yasuda K; Kanamori C; Kajimoto M; Nishigaki A; Tsuzuki T; Cho H; Okada H; Kanzaki H
    J Nat Med; 2014 Jul; 68(3):550-60. PubMed ID: 24740432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The efficacy of prophylactic Shakuyaku-Kanzo-to for myalgia and arthralgia following carboplatin and paclitaxel combination chemotherapy for non-small cell lung cancer.
    Yoshida T; Sawa T; Ishiguro T; Horiba A; Minatoguchi S; Fujiwara H
    Support Care Cancer; 2009 Mar; 17(3):315-20. PubMed ID: 18839222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of extrapyramidal symptoms during acute neuroleptic treatment.
    Mazure CM; Cellar JS; Bowers MB; Nelson JC; Takeshita J; Zigun B
    J Clin Psychiatry; 1995 Mar; 56(3):94-100. PubMed ID: 7883736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.